An Economic Evaluation of the JNC Hypertension Guidelines Using Data From a Randomized Controlled Trial

Abstract
Background: We wanted to determine the clinical cost of managing hypertension when following the Joint National Committee on Hypertension (JNC) guidelines, including drug therapy, the cost of monitoring for and treating side effects, compliance, and the cost of switching after therapeutic failures.

This publication has 0 references indexed in Scilit: